RBBP7 Antibody (N-term) Blocking Peptide

The synthetic peptide sequence used to generate the antibody was selected from the N-term region of human RBBP7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

[Histone-binding protein RBBP7; Histone-binding protein RBBP7; histone-binding protein RBBP7; RB binding protein 7, chromatin remodeling factor; Histone acetyltransferase type B subunit 2; Nucleosome-remodeling factor subunit RBAP46; Retinoblastoma-binding protein 7; RBBP-7; Retinoblastoma-binding protein p46]